![Daniel Simon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Simon
Corporate Officer/Principal bei
IDEAYA BIOSCIENCES, INC.
Profil
Daniel A. Simon is Chief Business Officer at IDEAYA Biosciences, Inc. since 2024.
Formerly, Chief Business Officer at Revolution Medicines, Inc. from 2022 to 2024.
Senior VP-Biopharma Business Development at Guardant Health, Inc. from 2015 to 2022.
Education includes graduate studies at the University of Cambridge and an MBA from The Wharton School of the University of Pennsylvania.
Aktive Positionen von Daniel Simon
| Unternehmen | Position | Beginn |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Corporate Officer/Principal | 01.08.2024 |
Ehemalige bekannte Positionen von Daniel Simon
| Unternehmen | Position | Ende |
|---|---|---|
| REVOLUTION MEDICINES, INC. | Corporate Officer/Principal | 01.01.2024 |
| GUARDANT HEALTH, INC. | Corporate Officer/Principal | 01.01.2022 |
Ausbildung von Daniel Simon
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
46
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Guardant Health, Inc.
 Guardant Health, Inc. Medical SpecialtiesHealth Technology Develops blood and tissue test devices to detect cancer & provides related screening services | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Revolution Medicines, Inc.
 Revolution Medicines, Inc. Pharmaceuticals: OtherHealth Technology Develops new therapies derived from natural products | Health Technology |
IDEAYA Biosciences, Inc.
 IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
